Saturday, August 22, 2026

Bukwang Pharmaceutical builds turnaround momentum, eyes Parkinson’s drug progress in second half

Bukwang Pharmaceutical is advancing its Parkinson’s treatment CP-012 into a global Phase 2 trial while enhancing RNA technology and manufacturing.

Tesla, Rivian, and Lucid Surge in EV Rally—But Nikola Takes a 12% Dive

U.S. EV stocks surged, led by Tesla's 5.77% gain, while Nikola fell 12.80% amid financial struggles and speculation.

Did North Korea Really Want to Ditch Its Nukes? Insights from Historic Talks

North Korea's positive response on disarming nuclear and chemical weapons is confirmed through inter-Korean meeting records.

Tag: Kihyun

No posts to display

Top News

- Our Sponsors Ad -

Follow us